Table 2.
N | Age (years) Median |
Normetanephrine (nmol/L)
|
Metanephrine (nmol/L)
|
|||||
---|---|---|---|---|---|---|---|---|
Median | 97.5 percentile | 2.5 percentile | Median | 97.5 percentile | 2.5 percentile | |||
All subjects | 1226 | 41.0 | 0.298 | 0.706 | 0.120 | 0.147 | 0.325 | 0.031 |
Women | 679 | 40.2 | 0.293 | 0.710 | 0.125 | 0.132* | 0.315 | 0.035 |
Men | 547 | 41.0 | 0.302 | 0.704 | 0.120 | 0.170† | 0.329 | 0.030 |
5–17 y | 116 | 13.2 | 0.248* | 0.470 | 0.048 | 0.172† | 0.333 | 0.045 |
18–29 y | 229 | 24.7 | 0.251* | 0.588 | 0.118 | 0.137* | 0.264 | 0.034 |
30–39 y | 232 | 34.5 | 0.273*† | 0.618 | 0.126 | 0.138* | 0.304 | 0.014 |
40–49 y | 283 | 45.0 | 0.300† | 0.687 | 0.115 | 0.147*† | 0.324 | 0.031 |
50–59 y | 241 | 53.0 | 0.362§ | 0.747 | 0.136 | 0.157† | 0.375 | 0.046 |
>60 y | 125 | 65.4 | 0.355§ | 1.047 | 0.137 | 0.163† | 0.358 | 0.051 |
Presence of different symbols (*†§) indicates differences (P < 0.005) in normetanephrine or metanephrine between men and women or among different age groups